documents_dir: ./documents/MigrainePreventionInChildren
model_name: gpt-4o-2024-11-20

chunk_size: 500
overlap: 100
indication: migraine_prevention_in_children

questions:
  - According to current guidelines, how well did treatments for the prophylaxis of migraine in children perform in clinical trials compared to placebo?
  - According to current guidelines, are there any psychiatric comorbidities that are recommended to screen for when treating children with migraine?
  - According to current gudielines, in case topiramate or valproic acid are considered for the prophylaxis of migraine in children, what are the recommended supplements in certain populations?
  - According to current guidelines, what medication that is used for the prophylaxis of migraine in children is known to decrease the efficacy of oral combined hormonal contraceptives?
  - According to current guidelines, which medication that is used for the prophylaxis of migraine in children is known to increase the risk of suicide?
  - The parents of a 12-year-old girl bring her to a neurologist due to frequent and debilitating migraine headaches. They are concerned about her quality of life and ask about treatment options for preventing migraines. They have heard about preventive medications and wonder how effective these treatments are in children. After explaining the available medications, they ask whether these treatments have been found to perform significantly better than non-active interventions in clinical trials involving children. How should the neurologist address their concern based on current guidelines?
  - The parents of a 10-year-old boy bring him to a pediatric neurologist due to frequent migraines that have begun affecting his school performance and social life. During the consultation, they mention that he often seems withdrawn and occasionally anxious. The neurologist considers how to best support the child beyond just treating his migraines. What additional screenings should the neurologist recommend according to current guidelines?
  - A 15-year-old female patient presents with chronic migraines that have been affecting her daily life, despite trials of several initial treatments. After discussing the options, the neurologist recommends topiramate for migraine prevention. The patient's mother expresses concern about making sure her daughter is well-supported while starting a new medication, particularly given her age and future health. How should the neurologist approach their concerns and ensure any additional needs are addressed according to current guidelines?
  - A 16-year-old female patient presents to her neurologist for the management of chronic migraines. The neurologist discusses potential preventive treatment options. During the conversation, the patient mentions that she uses oral combined hormonal contraceptives. The neurologist considers whether any of the suggested treatments might require extra attention or adjustment due to her contraceptive use. What should the neurologist take into consideration according to current guidelines when prescribing prophylactic medication in this situation?
  - A 14-year-old female patient presents with chronic migraines that significantly impact her school and social activities. After a thorough evaluation, her neurologist recommends starting a preventive medication. During the discussion, the patient's mother expresses concern about any potential mental health risks associated with migraine treatments, given a family history of depression. The neurologist considers this information carefully while determining the best treatment strategy. What specific precautions and patient counseling should the neurologist undertake according to current guidelines, especially with regard to any increased risks related to mental health, according to current guidelines?